| Product Code : | Pyobacteriophage 100 ml |
| Availability : | In Stock |
-
$79.00
Shipping time 12-14 days.
Ask a question
Expiration date until 07.24
TRADE NAME
Complex pyobacteriophage
DOSAGE FORM
Solution for oral, local and external administration
SHELF LIFE
2 years
MANUFACTURER
NPO Microgen, 177, Bratskaya str., Perm, Perm Territory, 614089 Russia
Presentation
20 ml, 100 ml vials Eight 20ml vials in each cardboard package with a package insert. One 100ml vials in each cardboard package with a package insert.Ingredients
1 ml of the drug contains the active substance:- sterile filtrate of phage lysates of Staphylococcus, Enterococcus, Strep-tococcus, Pseudomonas aeruginosa, Klebsiella pneumoniae, Klebsiella oxytoca, enteropathogenic Escherichia coli, Proteus vulgaris, P.mirabilis - 1 ml.
- preservative - 8-hydroxyquinoline sulfate monohydrate - 0.0001 g/ml (estimated content); or
- 8-hydroxyquinoline sulfate monohydrate - 0.0001 g/ml (equal to 8-hydroxyquinoline sulfate, estimated content).
Indications
- diseases of the ear, nose, throat, respiratory tract and lungs - inflammation of the sinuses, middle ear, tonsillitis, pharyngitis, laryngitis, tracheitis, bronchitis, pneumonia, pleurisy;
- surgical infections - festering wounds, burns, abscesses, cellulitis, boils, carbuncles, hidradenitis, felon, perirectitis, mastitis, bursitis, osteomyelitis;
- urogenital infections - urethritis, cystitis, pyelonephritis, colpitis, endometritis, salpingo-oophoritis;
- post-traumatic conjunctivitis, keratoconjunctivitis, purulent corneal ulcers and iridocyclitis;
- enteric infections - gastroenterocolitis, cholecystitis, dysbiosis;
- Generalized septic diseases;
- purulent inflammatory diseases of newborns - omphalitis, pyoderma, conjunctivitis, gastroenterocolitis, sepsis, etc.;
- other diseases caused by staphylococci, streptococci, enterococci, Proteus, Klebsiella pneumoniae and klebsiella oxytoca, Pseudomonas aeruginosa and Escherichia coli.
- For the prevention purposes the drug is use for the treatment of operational and newly infected wounds, for the prevention of hospital-acquired infections on epidemic indications.
- An important condition for the effective phage therapy is a preliminary determination of the phage sensitivity of the pathogen.
Permitted to buy without prescription